SHL Siemens Healthineers AG

XETRA · DE · Healthcare · Medical Devices · siemens-healthineers.com

37.40EUR-1.22%Mkt Cap: 46.06B $P/E: 19.22Today

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS,…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap46.06B USD

Enterprise Value59.69B USD

Revenue (TTM)25.18B USD

Gross Profit9.83B USD

Net Income (TTM)2.41B USD

Revenue/Share20.67 EUR

Last Price37.40 EUR

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees74.3K

CountryDE

SectorHealthcare

IndustryMedical Devices

ISINDE000SHL1006

Valuation

P/E (Trailing)19.22

P/E (Forward)15.96

PEG1.74

EV/EBITDA13.65

EV/Revenue2.37

P/S1.83

P/B2.21

EPS (TTM)1.97

EPS (Forward)2.37

52W Range

32.8127% of range49.71

52W High49.71 EUR

52W Low32.81 EUR

Profitability

Gross Margin39.02%

Oper. Margin16.41%

EBITDA Margin17.36%

Profit Margin9.55%

ROE12.15%

ROA4.48%

Growth

Revenue Growth1.80%

Earnings Growth22.40%

Cash Flow & Leverage

Operating CF3.72B USD

CapEx (TTM)—

FCF Margin9.26%

FCF Yield5.06%

Net Debt13.74B USD

Net Debt/EBITDA3.14

Balance Sheet

Debt/Equity78.30

Current Ratio1.16

Quick Ratio0.70

Book Value/Sh17.13 EUR

Cash/Share2.12 EUR

Dividends

Fwd Div Rate1.00 EUR

Trail. Div Rate1.00 EUR

Div. Yield2.64%

5Y Avg Yield1.86%

Payout Ratio50.76%

Ex-Div DateFeb 6, 2026

Pay Date—

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)45.52 EUR

Upside (mean)+21.7%

Target Range36.00 EUR – 57.40 EUR

36.00+21.7% to mean57.40

# Analysts19

Ownership

Shares Out.1.12B

Float357.71M

Insiders67.02%

Institutions13.69%

Technical

SMA 5038.62 (-3.2%)

SMA 20038.22 (-2.1%)

Beta0.83

S&P 52W Chg14.58%

Avg Vol (30d)945.93K

Avg Vol (10d)945.02K

Technical Indicators

RSI (14)47.9

MACD0.2938

MACD Signal0.6142

MACD Hist.-0.3204

BB Upper40.24 EUR

BB Middle38.96 EUR

BB Lower37.67 EUR

BB Width6.61%

ATR (14)0.8676 EUR

Vol Ratio (20d)0.89x